KaoYH. 2021. Yes, the Holy Gray exists. Learn from modern radioembolisation Eur J Nucl Med Mol Imaging, 48:4115–4117.
2.
KaoYH. 2013. Results confounded by a disregard for basic dose-response radiobiology. J Nucl Med, 54:1682–1683.
3.
Simões-PereiraJ, FerreiraTC, LimbertE, et al.2021. Outcomes of thyrotropin alfa versus levothyroxine withdrawal-aided radioiodine therapy for distant metastasis of papillary thyroid cancer. Thyroid, 31:1514–1522.
4.
HänscheidH, CanziC, EschnerW, et al.2013. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging, 40:1126–1134.
5.
PötziC, MoameniA, KaranikasG, et al.2006. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients. Clin Endocrinol (Oxf), 65:519–523.